Lori Taylor
Company: Annexon Biosciences
Job title: Senior Vice President – Portfolio Strategy & Operations
Seminars:
Optimizing Clinical Outcomes Utilizing Complement Mediators in Ophthalmic Indications: Are All Complement Pathways Equal? 2:30 pm
Assess potential distinct roles for the Classical and Alternative Pathways in Age-Related Macular Degeneration (AMD) Describe the clinical outcomes with distinct complement approaches (Factor B, C3, C5, C1q) Debate the role of local versus systemic complement in AMDRead more
day: Conference Day Two